beta3-Adrenergic Agonist [EPC]

beta3-Adrenergic Agonist [EPC] was reported 47774 times

These side effects are most commonly reported by patients taking drugs of the beta3-Adrenergic Agonist [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 7142
1 OFF LABEL USE 3012
2 HEADACHE 2713
3 FATIGUE 2663
4 DIZZINESS 2525
5 DIARRHOEA 2487
6 FALL 2289
7 NAUSEA 2108
8 PAIN 2102
9 ASTHENIA 1767
10 URINARY TRACT INFECTION 1744
11 HYPERTENSION 1665
12 RASH 1657
13 ARTHRALGIA 1654
14 DRY MOUTH 1652
15 CONSTIPATION 1611
16 BLOOD PRESSURE INCREASED 1602
17 DYSPNOEA 1574
18 INTENTIONAL PRODUCT MISUSE 1556
19 CONFUSIONAL STATE 1548
20 CONDITION AGGRAVATED 1543
21 VOMITING 1405
22 DEATH 1400
23 PERIPHERAL SWELLING 1399
24 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1358
25 ABDOMINAL PAIN UPPER 1337
26 INSOMNIA 1314
27 MALAISE 1304
28 MEMORY IMPAIRMENT 1302
29 NASOPHARYNGITIS 1277
30 HYPOAESTHESIA 1275
31 PNEUMONIA 1267
32 DEPRESSION 1249
33 PRODUCT USE IN UNAPPROVED INDICATION 1223
34 MUSCLE SPASMS 1199
35 INTENTIONAL PRODUCT USE ISSUE 1182
36 PAIN IN EXTREMITY 1164
37 ABDOMINAL DISCOMFORT 1150
38 URINARY RETENTION 1142
39 PARAESTHESIA 1115
40 GASTROOESOPHAGEAL REFLUX DISEASE 1084
41 URINARY INCONTINENCE 1082
42 GAIT DISTURBANCE 1077
43 POLLAKIURIA 1075
44 JOINT SWELLING 1041
45 ALOPECIA 996
46 WEIGHT INCREASED 979
47 NOCTURIA 975
48 URTICARIA 970
49 PRURITUS 961
50 MIGRAINE 960
51 INFUSION RELATED REACTION 943
52 MUSCULAR WEAKNESS 935
53 DRUG INTOLERANCE 928
54 MATERNAL EXPOSURE DURING PREGNANCY 915
55 GENERAL PHYSICAL HEALTH DETERIORATION 908
56 PRODUCT USE ISSUE 888
57 MOBILITY DECREASED 883
58 DRUG HYPERSENSITIVITY 878
59 RHEUMATOID ARTHRITIS 865
60 PRODUCT DOSE OMISSION ISSUE 852
61 SWELLING 850
62 DECREASED APPETITE 847
63 BACK PAIN 845
64 COUGH 830
65 BLEPHAROSPASM 825
66 THERAPEUTIC PRODUCT EFFECT DECREASED 817
67 C-REACTIVE PROTEIN INCREASED 815
68 TASTE DISORDER 813
69 OSTEOARTHRITIS 809
70 PSORIATIC ARTHROPATHY 805
71 SLEEP DISORDER 805
72 TYPE 2 DIABETES MELLITUS 803
73 EPILEPSY 802
74 SYNOVITIS 801
75 GLOSSODYNIA 790
76 FOLLICULITIS 773
77 IRRITABLE BOWEL SYNDROME 771
78 PEMPHIGUS 769
79 SYSTEMIC LUPUS ERYTHEMATOSUS 763
80 HEPATIC ENZYME INCREASED 761
81 INFLAMMATION 761
82 BLISTER 758
83 BURSITIS 757
84 WOUND 751
85 PERICARDITIS 742
86 WEIGHT DECREASED 732
87 BLOOD CHOLESTEROL INCREASED 726
88 IMPAIRED HEALING 725
89 FIBROMYALGIA 720
90 WHEEZING 719
91 LUNG DISORDER 715
92 FEELING ABNORMAL 711
93 NIGHT SWEATS 711
94 LOWER RESPIRATORY TRACT INFECTION 707
95 ARTHROPATHY 705
96 STOMATITIS 698
97 HYPERSENSITIVITY 693
98 GAIT INABILITY 690
99 DYSPEPSIA 686
100 NECK PAIN 673
101 HALLUCINATION 672
102 ANXIETY 670
103 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 664
104 FACET JOINT SYNDROME 663
105 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 662
106 PERIPHERAL VENOUS DISEASE 658
107 BREAST CANCER STAGE III 657
108 DUODENAL ULCER PERFORATION 652
109 HELICOBACTER INFECTION 652
110 PRODUCT QUALITY ISSUE 649
111 CONTRAINDICATED PRODUCT ADMINISTERED 646
112 HAND DEFORMITY 643
113 PYREXIA 641
114 SOMNOLENCE 639
115 ABDOMINAL PAIN 637
116 MUSCULOSKELETAL PAIN 637
117 MUSCLE INJURY 631
118 HYPERCHOLESTEROLAEMIA 626
119 JOINT RANGE OF MOTION DECREASED 626
120 COVID-19 617
121 TREATMENT FAILURE 613
122 WOUND INFECTION 610
123 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 609
124 OBESITY 601
125 LIP DRY 588
126 NAIL DISORDER 570
127 ONYCHOMADESIS 567
128 TREATMENT NONCOMPLIANCE 567
129 ABDOMINAL DISTENSION 566
130 GASTROINTESTINAL DISORDER 564
131 MUSCULOSKELETAL STIFFNESS 562
132 BALANCE DISORDER 557
133 LIVER INJURY 550
134 BACK INJURY 544
135 DYSURIA 543
136 ILL-DEFINED DISORDER 530
137 DRUG EFFECT INCOMPLETE 522
138 TREMOR 518
139 RHINORRHOEA 503
140 INJURY 491
141 CONTUSION 488
142 VISION BLURRED 486
143 CHEST PAIN 483
144 HYPOTENSION 478
145 LIVER FUNCTION TEST INCREASED 477
146 MICTURITION URGENCY 476
147 DRUG INTERACTION 474
148 RHEUMATIC FEVER 454
149 INFECTION 428
150 OEDEMA PERIPHERAL 424
151 LIVE BIRTH 420
152 INABILITY TO AFFORD MEDICATION 409
153 ONYCHOMYCOSIS 405
154 VISUAL IMPAIRMENT 404
155 EXPOSURE DURING PREGNANCY 397
156 SINUSITIS 392
157 OVERDOSE 385
158 INJECTION SITE REACTION 382
159 CYSTITIS 380
160 DYSPHAGIA 380
161 HOT FLUSH 379
162 ILLNESS 378
163 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 375
164 GRIP STRENGTH DECREASED 374
165 C-REACTIVE PROTEIN ABNORMAL 373
166 DISCOMFORT 355
167 ADVERSE EVENT 351
168 THERAPY INTERRUPTED 349
169 HOSPITALISATION 347
170 OROPHARYNGEAL PAIN 347
171 LOSS OF CONSCIOUSNESS 341
172 DRUG-INDUCED LIVER INJURY 337
173 CEREBROVASCULAR ACCIDENT 333
174 ATRIAL FIBRILLATION 332
175 PALPITATIONS 332
176 ERYTHEMA 330
177 DEHYDRATION 329
178 HEART RATE INCREASED 328
179 UNDERDOSE 324
180 ASTHMA 322
181 MYALGIA 318
182 DRUG EFFECT LESS THAN EXPECTED 315
183 PARKINSON^S DISEASE 314
184 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 311
185 ACUTE KIDNEY INJURY 308
186 DRY EYE 301
187 INFLUENZA 300
188 AMNESIA 285
189 HYPERHIDROSIS 285
190 FINGER DEFORMITY 283
191 COELIAC DISEASE 276
192 MULTIPLE SCLEROSIS 275
193 BLOOD GLUCOSE INCREASED 272
194 HEPATITIS 271
195 ADVERSE REACTION 269
196 FEELING HOT 266
197 INCORRECT DOSE ADMINISTERED 265
198 PRODUCT AVAILABILITY ISSUE 259
199 DELIRIUM 258
200 FLUSHING 257
201 ADVERSE DRUG REACTION 256
202 BRONCHITIS 254
203 ANAEMIA 251
204 INFUSION SITE REACTION 251
205 BLOOD PRESSURE DECREASED 249
206 MULTIPLE SCLEROSIS RELAPSE 247
207 ARTHRITIS 244
208 NASAL CONGESTION 243
209 CHRONIC KIDNEY DISEASE 239
210 DYSKINESIA 238
211 OEDEMA 235
212 NO ADVERSE EVENT 234
213 DRUG DOSE OMISSION 233
214 DEMENTIA 229
215 EYE PAIN 229
216 BLADDER DISORDER 227
217 CONGENITAL ANOMALY 226
218 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 222
219 COGNITIVE DISORDER 221
220 NEUROPATHY PERIPHERAL 220
221 PRODUCT LABEL CONFUSION 218
222 SEIZURE 218
223 HYPERTONIC BLADDER 217
224 SYNCOPE 216
225 INCONTINENCE 213
226 SEPSIS 212
227 DRY SKIN 211
228 INJECTION SITE PAIN 211
229 BURNING SENSATION 209
230 OSTEOPOROSIS 209
231 CHEST DISCOMFORT 208
232 DYSPHONIA 205
233 PRESCRIBED UNDERDOSE 196
234 PRESCRIBED OVERDOSE 195
235 CHILLS 193
236 RENAL IMPAIRMENT 192
237 PRODUCTIVE COUGH 191
238 CELLULITIS 189
239 EXOSTOSIS 189
240 TACHYCARDIA 187
241 HALLUCINATION, VISUAL 186
242 VERTIGO 185
243 HEAD INJURY 182
244 FLATULENCE 181
245 LOWER LIMB FRACTURE 181
246 RENAL FAILURE 181
247 WHITE BLOOD CELL COUNT DECREASED 181
248 SPEECH DISORDER 180
249 FOETAL EXPOSURE DURING PREGNANCY 179
250 DYSSTASIA 178
251 STRESS 178
252 SURGERY 178
253 SWELLING FACE 178
254 THERAPY CESSATION 176
255 EAR PAIN 175
256 MYOCARDIAL INFARCTION 174
257 BLOOD PRESSURE SYSTOLIC INCREASED 173
258 LIP SWELLING 173
259 OXYGEN SATURATION DECREASED 172
260 INFLUENZA LIKE ILLNESS 171
261 THERAPY NON-RESPONDER 171
262 RASH PRURITIC 170
263 CARDIAC DISORDER 169
264 LARYNGITIS 168
265 DEVICE ISSUE 166
266 SCIATICA 166
267 NEPHROLITHIASIS 164
268 ROAD TRAFFIC ACCIDENT 164
269 FREQUENT BOWEL MOVEMENTS 163
270 THROMBOSIS 161
271 EYE IRRITATION 159
272 CATARACT 158
273 LETHARGY 158
274 PRODUCT DOSE OMISSION 158
275 BLOOD PRESSURE FLUCTUATION 157
276 BLOOD URINE PRESENT 155
277 CHROMATURIA 155
278 CROHN^S DISEASE 155
279 EPISTAXIS 155
280 HIP FRACTURE 155
281 HYPOACUSIS 155
282 DISLOCATION OF VERTEBRA 154
283 FLUID RETENTION 153
284 CARDIAC FAILURE CONGESTIVE 152
285 PRODUCT DOSE OMISSION IN ERROR 152
286 RED BLOOD CELL SEDIMENTATION RATE INCREASED 152
287 HAEMOGLOBIN DECREASED 151
288 INTENTIONAL DRUG MISUSE 148
289 PULMONARY FIBROSIS 148
290 UPPER RESPIRATORY TRACT INFECTION 148
291 JOINT STIFFNESS 147
292 SWOLLEN JOINT COUNT INCREASED 147
293 URINE FLOW DECREASED 147
294 PSORIASIS 146
295 AGITATION 144
296 RECTAL HAEMORRHAGE 143
297 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 141
298 ARRHYTHMIA 139
299 HERPES ZOSTER 139
300 ACCIDENTAL OVERDOSE 138
301 DISTURBANCE IN ATTENTION 138
302 NIGHTMARE 138
303 THERAPEUTIC RESPONSE UNEXPECTED 136
304 CARDIAC FAILURE 135
305 DISORIENTATION 135
306 RESPIRATORY DISORDER 135
307 HYPERSOMNIA 134
308 DEPRESSED MOOD 132
309 MEDICATION ERROR 131
310 BLOOD PRESSURE ABNORMAL 129
311 PRODUCT DISPENSING ERROR 129
312 DELUSION 128
313 ORTHOSTATIC HYPOTENSION 126
314 HEPATIC CIRRHOSIS 125
315 KIDNEY INFECTION 125
316 PLATELET COUNT DECREASED 125
317 RHEUMATOID FACTOR POSITIVE 125
318 KNEE ARTHROPLASTY 124
319 UNEVALUABLE EVENT 124
320 DIABETES MELLITUS 123
321 PANCREATITIS 122
322 NEOPLASM MALIGNANT 121
323 ON AND OFF PHENOMENON 120
324 AUTOIMMUNE DISORDER 118
325 RENAL DISORDER 118
326 BLADDER PAIN 117
327 DRUG PRESCRIBING ERROR 117
328 EXPIRED PRODUCT ADMINISTERED 116
329 SLEEP APNOEA SYNDROME 115
330 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 114
331 SKIN EXFOLIATION 114
332 HAEMORRHAGE 113
333 LIVER DISORDER 112
334 MOVEMENT DISORDER 112
335 NERVOUSNESS 112
336 APHASIA 111
337 DEEP VEIN THROMBOSIS POSTOPERATIVE 111
338 PULMONARY EMBOLISM 111
339 LIMB INJURY 110
340 PRODUCT PRESCRIBING ERROR 110
341 SWOLLEN TONGUE 110
342 ABNORMAL DREAMS 109
343 BREAST CANCER STAGE II 109
344 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 109
345 BLADDER SPASM 108
346 DYSGEUSIA 107
347 PLEURAL EFFUSION 107
348 ANAL INCONTINENCE 106
349 DYSARTHRIA 106
350 LIMB DISCOMFORT 106
351 LUPUS VULGARIS 106
352 WHITE BLOOD CELL COUNT INCREASED 106
353 HAEMATURIA 105
354 INCORRECT PRODUCT ADMINISTRATION DURATION 105
355 MIDDLE INSOMNIA 105
356 OCULAR HYPERAEMIA 105
357 THROAT IRRITATION 105
358 TINNITUS 105
359 BONE EROSION 104
360 DEVICE DISLOCATION 104
361 INTENTIONAL DOSE OMISSION 104
362 RESPIRATORY TRACT INFECTION 104
363 DISEASE PROGRESSION 103
364 FUNGAL INFECTION 103
365 OVERLAP SYNDROME 103
366 PRODUCT PACKAGING QUANTITY ISSUE 103
367 DIPLOPIA 101
368 EYE SWELLING 101
369 NEURALGIA 100
370 BONE PAIN 99
371 HYPOCHOLESTEROLAEMIA 99
372 HYPOTHYROIDISM 99
373 INTESTINAL OBSTRUCTION 99
374 LACRIMATION INCREASED 99
375 SUICIDAL IDEATION 99
376 EAR INFECTION 98
377 RIB FRACTURE 98
378 HYPOKALAEMIA 97
379 MUSCLE SPASTICITY 97
380 SINUS DISORDER 97
381 X-RAY ABNORMAL 97
382 GASTROINTESTINAL HAEMORRHAGE 96
383 NORMAL NEWBORN 96
384 ABNORMAL BEHAVIOUR 95
385 BACK DISORDER 95
386 PRODUCT STORAGE ERROR 95
387 RESTLESSNESS 95
388 BLOOD CREATININE INCREASED 94
389 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 93
390 LUPUS-LIKE SYNDROME 92
391 WALKING AID USER 92
392 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 90
393 HEART RATE DECREASED 90
394 ULCER HAEMORRHAGE 90
395 HYPONATRAEMIA 88
396 AGGRESSION 87
397 THERAPEUTIC RESPONSE DECREASED 87
398 ANGIOEDEMA 86
399 CEREBRAL HAEMORRHAGE 86
400 POOR QUALITY SLEEP 86
401 HIP ARTHROPLASTY 85
402 BLOOD SODIUM DECREASED 84
403 EYE DISORDER 84
404 INTERVERTEBRAL DISC PROTRUSION 84
405 THROMBOCYTOPENIA 84
406 ELECTROCARDIOGRAM QT PROLONGED 83
407 PNEUMONIA ASPIRATION 83
408 ERECTILE DYSFUNCTION 82
409 URINE ODOUR ABNORMAL 81
410 HEPATIC ENZYME 80
411 NEUTROPENIA 80
412 SPINAL OPERATION 80
413 ORAL PAIN 79
414 RASH MACULAR 79
415 THERAPEUTIC RESPONSE SHORTENED 79
416 TRANSIENT ISCHAEMIC ATTACK 79
417 EMOTIONAL DISTRESS 78
418 SKIN DISCOLOURATION 78
419 ALANINE AMINOTRANSFERASE INCREASED 77
420 ANAPHYLACTIC REACTION 77
421 DEEP VEIN THROMBOSIS 77
422 DISABILITY 77
423 LYMPHOCYTE COUNT DECREASED 77
424 SEASONAL ALLERGY 77
425 SKIN LACERATION 77
426 ANGINA PECTORIS 76
427 COLITIS ULCERATIVE 76
428 DYSPNOEA EXERTIONAL 76
429 INJECTION SITE BRUISING 76
430 INJECTION SITE ERYTHEMA 76
431 LABORATORY TEST ABNORMAL 76
432 MUSCULOSKELETAL DISCOMFORT 76
433 PROSTATE CANCER 76
434 RESPIRATORY FAILURE 76
435 DRUG TOLERANCE 75
436 GLAUCOMA 75
437 RETINITIS 75
438 THERAPEUTIC PRODUCT EFFECT VARIABLE 75
439 THIRST 75
440 INSURANCE ISSUE 74
441 MALIGNANT NEOPLASM PROGRESSION 74
442 MENTAL DISORDER 74
443 THROAT TIGHTNESS 74
444 DRY THROAT 73
445 FREEZING PHENOMENON 73
446 INFUSION SITE PAIN 73
447 PRODUCT USE COMPLAINT 73
448 PULMONARY OEDEMA 73
449 FAECES DISCOLOURED 72
450 HEAD DISCOMFORT 72
451 HYPOPHAGIA 72
452 LOCALISED INFECTION 72
453 DIZZINESS POSTURAL 71
454 ECZEMA 71
455 IRRITABILITY 71
456 SKIN CANCER 71
457 ASPIRATION 70
458 CLOSTRIDIUM DIFFICILE INFECTION 70
459 FEMUR FRACTURE 70
460 INTERSTITIAL LUNG DISEASE 70
461 MUSCLE RIGIDITY 70
462 DIVERTICULITIS 69
463 HAEMATOCHEZIA 69
464 JOINT INJURY 69
465 RASH ERYTHEMATOUS 69
466 RED BLOOD CELL COUNT DECREASED 69
467 SKIN LESION 69
468 MUSCLE TWITCHING 68
469 PRESYNCOPE 68
470 UPPER LIMB FRACTURE 68
471 URINARY HESITATION 68
472 BRAIN FOG 67
473 DERMATITIS ATOPIC 67
474 DRUG EFFECT DECREASED 67
475 FEEDING DISORDER 67
476 RESTLESS LEGS SYNDROME 67
477 FEELING COLD 66
478 HEART RATE IRREGULAR 66
479 SNEEZING 66
480 BLOOD POTASSIUM DECREASED 65
481 INJECTION SITE PRURITUS 65
482 VIRAL INFECTION 65
483 ASPARTATE AMINOTRANSFERASE INCREASED 64
484 CEREBRAL INFARCTION 64
485 EYE PRURITUS 64
486 FOOT DEFORMITY 64
487 HYPOKINESIA 64
488 ORAL CANDIDIASIS 64
489 URINE OUTPUT DECREASED 64
490 BRADYKINESIA 63
491 BLINDNESS 62
492 FOOT FRACTURE 62
493 GASTRIC DISORDER 62
494 MUSCULOSKELETAL DISORDER 62
495 BRADYCARDIA 61
496 BREAST CANCER 61
497 DEMENTIA ALZHEIMER^S TYPE 61
498 FEBRILE NEUTROPENIA 61
499 HYPERLIPIDAEMIA 61
500 INITIAL INSOMNIA 61
501 CANDIDA INFECTION 60
502 HAEMORRHOIDS 60
503 ORAL HERPES 60
504 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 60
505 TOXICITY TO VARIOUS AGENTS 60
506 DEVICE OCCLUSION 59
507 MENTAL STATUS CHANGES 59
508 URINARY TRACT DISORDER 59
509 ANKLE FRACTURE 58
510 CARDIAC ARREST 58
511 FRACTURE 58
512 SKIN DISORDER 58
513 ABDOMINAL PAIN LOWER 57
514 BODY TEMPERATURE INCREASED 57
515 COLITIS 57
516 DEPRESSED LEVEL OF CONSCIOUSNESS 57
517 HYPERTENSIVE CRISIS 57
518 INFUSION SITE ERYTHEMA 57
519 PROCEDURAL PAIN 57
520 PRODUCT SUBSTITUTION ISSUE 57
521 BLADDER CANCER 56
522 OSTEOPENIA 56
523 SEPTIC SHOCK 56
524 URINE OUTPUT INCREASED 56
525 FEELING JITTERY 55
526 HOSPICE CARE 55
527 HYPOGLYCAEMIA 55
528 LUNG NEOPLASM MALIGNANT 55
529 MENTAL IMPAIRMENT 55
530 PROSTATIC SPECIFIC ANTIGEN INCREASED 55
531 RASH GENERALISED 55
532 SINUS CONGESTION 55
533 UNRESPONSIVE TO STIMULI 55
534 PARANOIA 54
535 POST PROCEDURAL COMPLICATION 54
536 VITAMIN D DEFICIENCY 54
537 APHONIA 53
538 CRYING 53
539 GASTRITIS 53
540 HYPERKALAEMIA 53
541 INJECTION SITE SWELLING 53
542 INTENTIONAL OVERDOSE 53
543 MOOD ALTERED 53
544 PORPHYRIA ACUTE 53
545 PSYCHOTIC DISORDER 53
546 RETCHING 53
547 URGE INCONTINENCE 53
548 UROSEPSIS 53
549 CHOLELITHIASIS 52
550 EATING DISORDER 52
551 HYPERGLYCAEMIA 52
552 NONSPECIFIC REACTION 52
553 PANCYTOPENIA 52
554 PRODUCT COLOUR ISSUE 52
555 SPINAL FRACTURE 52
556 URINE ABNORMALITY 52
557 ACCIDENT 51
558 BOWEL MOVEMENT IRREGULARITY 51
559 ERUCTATION 51
560 HYPOXIA 51
561 JOINT DISLOCATION 51
562 MACULAR DEGENERATION 51
563 ACUTE MYOCARDIAL INFARCTION 50
564 CHOKING 50
565 EXTRA DOSE ADMINISTERED 50
566 NEUROGENIC BLADDER 50
567 NEUTROPHIL COUNT DECREASED 50
568 PELVIC PAIN 50
569 WEIGHT FLUCTUATION 50
570 WRONG TECHNIQUE IN DRUG USAGE PROCESS 50
571 ACCIDENTAL EXPOSURE TO PRODUCT 49
572 BENIGN PROSTATIC HYPERPLASIA 49
573 GLOMERULAR FILTRATION RATE DECREASED 49
574 INCREASED TENDENCY TO BRUISE 49
575 NERVOUS SYSTEM DISORDER 49
576 PERIPHERAL COLDNESS 49
577 PRODUCT ADMINISTRATION INTERRUPTED 49
578 SENSORY DISTURBANCE 49
579 TOOTH DISORDER 49
580 MUSCLE TIGHTNESS 48
581 PANIC ATTACK 48
582 STAPHYLOCOCCAL INFECTION 48
583 BLADDER DISCOMFORT 47
584 DEVICE MALFUNCTION 47
585 MYOSITIS 47
586 PAIN IN JAW 47
587 REHABILITATION THERAPY 47
588 ENURESIS 46
589 PRURITUS GENERALISED 46
590 ROTATOR CUFF SYNDROME 46
591 SARS-COV-2 TEST POSITIVE 46
592 DEAFNESS 45
593 DISEASE RECURRENCE 45
594 HERNIA 45
595 INFUSION SITE SWELLING 45
596 MYASTHENIA GRAVIS 45
597 PRODUCT ADMINISTRATION ERROR 45
598 DERMATITIS ALLERGIC 44
599 HAEMOPTYSIS 44
600 ORAL DISCOMFORT 44
601 ANGER 43
602 CONCUSSION 43
603 IMMUNODEFICIENCY 43
604 IMPAIRED GASTRIC EMPTYING 43
605 IRON DEFICIENCY ANAEMIA 43
606 KNEE OPERATION 43
607 MASS 43
608 PHARYNGITIS 43
609 PHOTOPHOBIA 43
610 SKIN FISSURES 43
611 TEMPERATURE INTOLERANCE 43
612 THERAPEUTIC PRODUCT EFFECT DELAYED 43
613 UPPER-AIRWAY COUGH SYNDROME 43
614 VULVOVAGINAL PRURITUS 43
615 CYSTITIS INTERSTITIAL 42
616 PALLOR 42
617 RESPIRATORY DISTRESS 42
618 SKIN ULCER 42
619 SPINAL STENOSIS 42
620 STOMA SITE DISCHARGE 42
621 THINKING ABNORMAL 42
622 AGEUSIA 41
623 BLOOD COUNT ABNORMAL 41
624 BLOOD GLUCOSE DECREASED 41
625 COLD SWEAT 41
626 DEVICE BREAKAGE 41
627 DEVICE LEAKAGE 41
628 IMPAIRED QUALITY OF LIFE 41
629 PULMONARY MASS 41
630 RASH VESICULAR 41
631 RESPIRATORY TRACT CONGESTION 41
632 RHABDOMYOLYSIS 41
633 BLOOD PRESSURE DIASTOLIC DECREASED 40
634 DECREASED ACTIVITY 40
635 FAECES SOFT 40
636 GASTROENTERITIS VIRAL 40
637 GOUT 40
638 HAEMATOMA 40
639 PHARYNGEAL SWELLING 40
640 SALIVARY HYPERSECRETION 40
641 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 40
642 BODY HEIGHT DECREASED 39
643 HEART RATE ABNORMAL 39
644 HEMIPARESIS 39
645 OCULAR DISCOMFORT 39
646 PELVIC FRACTURE 39
647 PERONEAL NERVE PALSY 39
648 PUSTULAR PSORIASIS 39
649 SKIN ABRASION 39
650 SKIN IRRITATION 39
651 SPINAL COMPRESSION FRACTURE 39
652 SUBDURAL HAEMATOMA 39
653 URINARY TRACT INFECTION BACTERIAL 39
654 ACUTE RESPIRATORY FAILURE 38
655 EMOTIONAL DISORDER 38
656 FRUSTRATION TOLERANCE DECREASED 38
657 INJECTION SITE MASS 38
658 LIBIDO DECREASED 38
659 NODULE 38
660 PARAESTHESIA ORAL 38
661 PLASMA CELL MYELOMA 38
662 PNEUMONITIS 38
663 POST PROCEDURAL INFECTION 38
664 PULMONARY THROMBOSIS 38
665 RENAL PAIN 38
666 TARDIVE DYSKINESIA 38
667 TOOTHACHE 38
668 WHITE BLOOD CELL COUNT ABNORMAL 38
669 DEVICE DIFFICULT TO USE 37
670 GLYCOSYLATED HAEMOGLOBIN INCREASED 37
671 HEPATIC FUNCTION ABNORMAL 37
672 HEPATIC STEATOSIS 37
673 LIGAMENT SPRAIN 37
674 POLYURIA 37
675 SENSORY LOSS 37
676 SUICIDE ATTEMPT 37
677 ATELECTASIS 36
678 BASAL CELL CARCINOMA 36
679 BEDRIDDEN 36
680 BLOOD POTASSIUM INCREASED 36
681 DECUBITUS ULCER 36
682 GASTROINTESTINAL MOTILITY DISORDER 36
683 HAEMATOCRIT DECREASED 36
684 HALLUCINATION, AUDITORY 36
685 HYSTERECTOMY 36
686 INTRAOCULAR PRESSURE INCREASED 36
687 MUSCLE STRAIN 36
688 NERVE INJURY 36
689 STOMA SITE ERYTHEMA 36
690 VAGINAL HAEMORRHAGE 36
691 WHEELCHAIR USER 36
692 ATAXIA 35
693 BLOOD PRESSURE DIASTOLIC ABNORMAL 35
694 CARPAL TUNNEL SYNDROME 35
695 COORDINATION ABNORMAL 35
696 DYSTONIA 35
697 HIATUS HERNIA 35
698 MOUTH ULCERATION 35
699 MULTIPLE ALLERGIES 35
700 PRODUCT DISTRIBUTION ISSUE 35
701 SMALL INTESTINAL OBSTRUCTION 35
702 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35
703 ALTERED STATE OF CONSCIOUSNESS 34
704 BLADDER OPERATION 34
705 BRONCHIECTASIS 34
706 COVID-19 PNEUMONIA 34
707 END STAGE RENAL DISEASE 34
708 GENERAL SYMPTOM 34
709 GROIN PAIN 34
710 HYPOAESTHESIA ORAL 34
711 INTENTIONAL UNDERDOSE 34
712 INTERCEPTED MEDICATION ERROR 34
713 NERVE COMPRESSION 34
714 POOR VENOUS ACCESS 34
715 PREGNANCY 34
716 SECRETION DISCHARGE 34
717 SKIN INFECTION 34
718 SPINAL PAIN 34
719 TOOTH FRACTURE 34
720 TUBULOINTERSTITIAL NEPHRITIS 34
721 COLON CANCER 33
722 DENTAL CARIES 33
723 ESSENTIAL HYPERTENSION 33
724 FULL BLOOD COUNT DECREASED 33
725 INTERNATIONAL NORMALISED RATIO INCREASED 33
726 MICTURITION DISORDER 33
727 MOUTH SWELLING 33
728 OSTEOMYELITIS 33
729 PROSTATOMEGALY 33
730 SPONDYLITIS 33
731 BLOOD IRON DECREASED 32
732 DROOLING 32
733 INCREASED APPETITE 32
734 LEUKOPENIA 32
735 LYMPHADENOPATHY 32
736 METASTASES TO LIVER 32
737 MOTOR DYSFUNCTION 32
738 OBSTRUCTIVE AIRWAYS DISORDER 32
739 PRODUCT PHYSICAL ISSUE 32
740 PRODUCT PRESCRIBING ISSUE 32
741 RENAL INJURY 32
742 SKIN HAEMORRHAGE 32
743 SPINAL DISORDER 32
744 TENDONITIS 32
745 VISUAL ACUITY REDUCED 32
746 ABNORMAL FAECES 31
747 BREAST PAIN 31
748 ENCEPHALOPATHY 31
749 ESCHERICHIA INFECTION 31
750 FAECALOMA 31
751 FAECES HARD 31
752 FLANK PAIN 31
753 INFUSION SITE HAEMORRHAGE 31
754 INJECTION SITE HAEMORRHAGE 31
755 MOOD SWINGS 31
756 NEOPLASM PROGRESSION 31
757 PNEUMOTHORAX 31
758 POLYP 31
759 POSTURE ABNORMAL 31
760 PRODUCT PACKAGING ISSUE 31
761 SEDATION 31
762 SPINAL OSTEOARTHRITIS 31
763 SUBARACHNOID HAEMORRHAGE 31
764 TONGUE DISCOMFORT 31
765 ACNE 30
766 BLOOD ALKALINE PHOSPHATASE INCREASED 30
767 CEREBRAL DISORDER 30
768 CHRONIC SINUSITIS 30
769 CYST 30
770 GASTROINTESTINAL INFECTION 30
771 MUSCULOSKELETAL CHEST PAIN 30
772 NASAL DRYNESS 30
773 ORAL DISORDER 30
774 SCHIZOPHRENIA 30
775 SLUGGISHNESS 30
776 THYROID DISORDER 30
777 TOOTH INFECTION 30
778 CATARACT OPERATION 29
779 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 29
780 EYE DISCHARGE 29
781 HAEMOGLOBIN ABNORMAL 29
782 HIP SURGERY 29
783 HUNGER 29
784 PERICARDIAL EFFUSION 29
785 PRE-EXISTING CONDITION IMPROVED 29
786 PRODUCT LABEL ISSUE 29
787 PRODUCT SIZE ISSUE 29
788 ADRENAL INSUFFICIENCY 28
789 BLINDNESS UNILATERAL 28
790 COMPLICATION ASSOCIATED WITH DEVICE 28
791 COMPRESSION FRACTURE 28
792 DEVICE RELATED INFECTION 28
793 EYE INFLAMMATION 28
794 HAIR TEXTURE ABNORMAL 28
795 HYDRONEPHROSIS 28
796 INFUSION SITE BRUISING 28
797 INTERVERTEBRAL DISC DEGENERATION 28
798 LOCAL SWELLING 28
799 NEEDLE ISSUE 28
800 OESOPHAGEAL DISORDER 28
801 ORAL MUCOSAL BLISTERING 28
802 PARALYSIS 28
803 PARANASAL SINUS DISCOMFORT 28
804 PHARYNGEAL OEDEMA 28
805 PROSTATIC DISORDER 28
806 SWOLLEN JOINT COUNT 28
807 VITREOUS FLOATERS 28
808 VULVOVAGINAL PAIN 28
809 WITHDRAWAL SYNDROME 28
810 APATHY 27
811 BLOOD CREATINE PHOSPHOKINASE INCREASED 27
812 BLOOD TEST ABNORMAL 27
813 BONE DENSITY DECREASED 27
814 CLOSTRIDIUM DIFFICILE COLITIS 27
815 DEMENTIA WITH LEWY BODIES 27
816 DERMATITIS CONTACT 27
817 DEVICE USE ISSUE 27
818 DRUG DISPENSING ERROR 27
819 DYSGRAPHIA 27
820 EYE INJURY 27
821 FACIAL PAIN 27
822 FEAR 27
823 FULL BLOOD COUNT ABNORMAL 27
824 GASTROINTESTINAL PAIN 27
825 ILEUS 27
826 INFUSION SITE EXTRAVASATION 27
827 INJECTION SITE URTICARIA 27
828 MALIGNANT MELANOMA 27
829 OROPHARYNGEAL DISCOMFORT 27
830 PLATELET COUNT INCREASED 27
831 PRODUCT RESIDUE PRESENT 27
832 RENAL CYST 27
833 TACHYPNOEA 27
834 VULVOVAGINAL BURNING SENSATION 27
835 ANHEDONIA 26
836 BACTERIAL INFECTION 26
837 C-REACTIVE PROTEIN 26
838 CORONARY ARTERY DISEASE 26
839 EAR DISCOMFORT 26
840 GOITRE 26
841 LYMPHOEDEMA 26
842 LYMPHOPENIA 26
843 MELAENA 26
844 MUSCLE ATROPHY 26
845 PARKINSONISM 26
846 PSYCHIATRIC SYMPTOM 26
847 PYELONEPHRITIS 26
848 SPUTUM DISCOLOURED 26
849 TOOTH EXTRACTION 26
850 VITAMIN D DECREASED 26
851 WRIST FRACTURE 26
852 ABASIA 25
853 APPLICATION SITE PRURITUS 25
854 CENTRAL NERVOUS SYSTEM LESION 25
855 FOREIGN BODY SENSATION IN EYES 25
856 HICCUPS 25
857 HYPERKINESIA 25
858 IMMOBILE 25
859 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 25
860 MACULOPATHY 25
861 OPTIC NEURITIS 25
862 PULMONARY CONGESTION 25
863 RASH PAPULAR 25
864 SCAR 25
865 SKIN BURNING SENSATION 25
866 SKIN ODOUR ABNORMAL 25
867 TENDON RUPTURE 25
868 THERAPY PARTIAL RESPONDER 25
869 ARTHROPOD BITE 24
870 BLADDER CATHETERISATION 24
871 BLOOD GLUCOSE FLUCTUATION 24
872 BLOOD UREA INCREASED 24
873 DERMATITIS 24
874 HAND FRACTURE 24
875 HYPERVENTILATION 24
876 HYPOMAGNESAEMIA 24
877 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 24
878 LIVER FUNCTION TEST ABNORMAL 24
879 MULTIPLE FRACTURES 24
880 PAIN OF SKIN 24
881 PERSONALITY CHANGE 24
882 PSYCHOMOTOR HYPERACTIVITY 24
883 SCOLIOSIS 24
884 SLEEP DEFICIT 24
885 ANXIETY DISORDER 23
886 APPLICATION SITE ERYTHEMA 23
887 BIPOLAR DISORDER 23
888 CARDIOMEGALY 23
889 DRUG TOLERANCE DECREASED 23
890 FUNCTIONAL GASTROINTESTINAL DISORDER 23
891 HAEMORRHAGE URINARY TRACT 23
892 IMPAIRED DRIVING ABILITY 23
893 MATERNAL EXPOSURE TIMING UNSPECIFIED 23
894 NEPHROGENIC ANAEMIA 23
895 PNEUMONIA BACTERIAL 23
896 RESIDUAL URINE VOLUME INCREASED 23
897 RHINITIS 23
898 STOMA SITE HAEMORRHAGE 23
899 TOOTH ABSCESS 23
900 URINE ANALYSIS ABNORMAL 23
901 ABSCESS 22
902 ACUTE CORONARY SYNDROME 22
903 BLOOD PRESSURE SYSTOLIC ABNORMAL 22
904 BODY TEMPERATURE DECREASED 22
905 BONE DISORDER 22
906 BREAST DISORDER 22
907 COMA 22
908 CYSTITIS NONINFECTIVE 22
909 EYE INFECTION 22
910 FACIAL PARALYSIS 22
911 FEELING DRUNK 22
912 GALLBLADDER DISORDER 22
913 HAEMORRHAGE INTRACRANIAL 22
914 INHIBITORY DRUG INTERACTION 22
915 INJECTION SITE RASH 22
916 LUMBAR VERTEBRAL FRACTURE 22
917 NASAL DISCOMFORT 22
918 PERIARTHRITIS 22
919 PULMONARY HYPERTENSION 22
920 SCAB 22
921 SENSITIVE SKIN 22
922 SKIN REACTION 22
923 SLOW SPEECH 22
924 SPUTUM RETENTION 22
925 THYROID MASS 22
926 VASCULITIS 22
927 VOLVULUS 22
928 ARTERIOSCLEROSIS CORONARY ARTERY 21
929 BLOOD GLUCOSE ABNORMAL 21
930 BLOOD MAGNESIUM DECREASED 21
931 BONE MARROW OEDEMA 21
932 DEVICE KINK 21
933 EXERCISE TOLERANCE DECREASED 21
934 EXPOSURE VIA SKIN CONTACT 21
935 EYE HAEMORRHAGE 21
936 HALLUCINATIONS, MIXED 21
937 HUMERUS FRACTURE 21
938 HYPOCALCAEMIA 21
939 IMMUNE SYSTEM DISORDER 21
940 LACERATION 21
941 ONYCHOCLASIS 21
942 PANCREATITIS ACUTE 21
943 POST-TRAUMATIC STRESS DISORDER 21
944 SHOULDER ARTHROPLASTY 21
945 SPINAL CORD INJURY 21
946 SPLENOMEGALY 21
947 TRANSFUSION 21
948 ASCITES 20
949 ATRIAL FLUTTER 20
950 BLOOD CALCIUM INCREASED 20
951 BREAST CANCER FEMALE 20
952 BRONCHIAL WALL THICKENING 20
953 CARDIAC FAILURE ACUTE 20
954 CARDIAC FLUTTER 20
955 CHOLECYSTECTOMY 20
956 CLOSTRIDIUM TEST POSITIVE 20
957 CORONAVIRUS INFECTION 20
958 DRUG DOSE OMISSION BY DEVICE 20
959 FOOT OPERATION 20
960 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20
961 GASTRIC ULCER 20
962 GASTROENTERITIS 20
963 HYPOVENTILATION 20
964 INFUSION SITE DISCHARGE 20
965 JOINT INSTABILITY 20
966 MALNUTRITION 20
967 PHARYNGEAL ERYTHEMA 20
968 PHOTOSENSITIVITY REACTION 20
969 PRODUCT ADHESION ISSUE 20
970 RED CELL DISTRIBUTION WIDTH INCREASED 20
971 STENT PLACEMENT 20
972 STEROID DIABETES 20
973 TENDON DISORDER 20
974 TENSION 20
975 UPPER AIRWAY OBSTRUCTION 20
976 UPPER RESPIRATORY TRACT INFLAMMATION 20
977 ACTIVITIES OF DAILY LIVING IMPAIRED 19
978 APHTHOUS ULCER 19
979 BLADDER DYSFUNCTION 19
980 BRAIN NEOPLASM 19
981 COMMUNICATION DISORDER 19
982 DECREASED INTEREST 19
983 ELECTROLYTE IMBALANCE 19
984 FORCED VITAL CAPACITY DECREASED 19
985 GENERALISED OEDEMA 19
986 INFUSION SITE PRURITUS 19
987 INGUINAL HERNIA 19
988 INTERNAL HAEMORRHAGE 19
989 LIVING IN RESIDENTIAL INSTITUTION 19
990 PERINEAL PAIN 19
991 PERIORBITAL SWELLING 19
992 PETECHIAE 19
993 PHYSICAL DECONDITIONING 19
994 QUALITY OF LIFE DECREASED 19
995 ROSACEA 19
996 SOMNAMBULISM 19
997 SPINAL FUSION SURGERY 19
998 STOMA SITE INFECTION 19
999 STRESS URINARY INCONTINENCE 19